iPHEX 2013 for global showcasing of Indian Pharma products
iPHEX 2013 shall be held in Mumbai from 24-26 April 2013 and over 250 companies including leading Indian companies like Aurobindo Ranbaxy, IPCA, Mankind ACG Worldwide, Ind-Swift, Indoco, Lupin, Troikaa, Mylan Laboratories, Zydus Cadila to mention few are expected to showcase the best of pharma products at the event.
- (1888PressRelease) March 08, 2013 - The Pharmaceuticals Export Promotion Council of India (Pharmexcil), has announced the launch of iPHEX 2013, India's own pharmaceutical show under the support of Ministry of Commerce & Industry, Department of Commerce, and Government of India.
iPHEX 2013 will see the presence of 5000 business visitors including overseas buyers and drug regulators. Pharmexcil has invited top representatives of International Association and proposed signing of MoUs for information exchange and other trade facilitation related co-operation for the mutual benefits of business people. Huge business opportunities are expected to emerge during the event. Further the presence of large number of drug regulators from overseas market will immensely help Pharmexcil and its members to promote the quality and affordability aspect as envisaged in Brand India Pharma Campaign. Participation of bigger companies along with SMEs lends credibility to this campaign as the entire Indian Pharma industry stands by its commitment to provide quality products. The campaign has been initiated by Ministry of Commerce and executed by Pharmaceuticals Export Promotion Council in association with I.B.E.F.
Over 100 SME companies have already registered with iPHEX 2013. The exhibition will provide a global reach to these SMEs who are constraint with resources in reaching out to potential markets. With support of Ministry of Commerce, Government of India, over 400 overseas importers including regulators are being invited to visit and meet exhibitors during the three day event. This will be a big opportunity for SMEs to explore the business opportunities under one roof all across the globe. Adding to it, the interaction with invited overseas regulators will provide a greater insight into the regulatory framework of respective countries.
iPHEX 2013 will be a complete value chain show and Pharmexcil is creating a sustainable pharma industry platform with a special focus on exports market development. "The exports growth story is one to be proud of," says Dr. P V Appaji Director General, Pharmexcil. "Total exports during the last five years have grown by 16% CAGR, growth during the last financial year, 2011-12 was 23.34% in USD terms. North America continues to be our best destination with a CAGR of 25% and 33% growth during 2011-12. Exports to EU has grown exceptionally well during 2011-12 with 28% considering the fact that a single digit CAGR was recorded during the last four years. Exports to Oceania have also grown well with a growth of 43% but the overall turnover is small and considering the fact that Australia and New Zealand are not yet fully tapped, higher growth rates can be expected," he mentioned.
"iPHEX 2013 will be the biggest industry exposition in India showcasing the diverse range of products and will include Formulations, APIs, Ayush, Nutraceuticals, Health Services, Biotechnology and Biotechnology Products, R & D Services etc. In addition to a world class exhibition and meeting place for Indian companies and global buyers, Pharmexcil plans to organise several thematic seminars and conferences on the sidelines as well. These shall include Pharma sector investments, R&D and Innovation, overseas market entry strategies etc," informed Mr. Bhavin Mehta Committee Chief of IPHEX and CoA member, Pharmexcil.
The Ministry of Commerce, has launched a series of initiatives to promote Brand India Pharma and iPHEX 2013 shall offer a perfect opportunity for international buyers and regulators to come to India and evaluate how well structured and regulated the Indian pharma industry is.
Note About the Organiser
iPHEX 2013 is being organised by Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) under the support of Ministry of Commerce & Industry, Department of Commerce, Government of India. Pharmexcil is:
- Nodal agency to represent Indian Drugs, Pharmaceutical and Healthcare industry globally
- Mandated to help over 3800 of its members to achieve excellence in export
- Facilitate overseas buyers to find suitable trade partners from Indian pharma industry
Please visit www.pharmexcil.com for more details.
For Further Details contact
Mediacom PR: 022 - 4028 0800
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam